Go to main content

Our ambition and approach

Our ambition is to become substantially smoke-free by 2030, with our smoke-free business generating over two-thirds of total global net revenues.

As of October 21, 2026 smoke-free products represented > 40% of our total global net revenues.

Smoke-free products are not risk-free and contain nicotine, which is addictive.

Our progress toward a smoke-free future as of Q3 2026
 

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_1

    40 percent

    of PMI’s total net revenues came from our smoke-free business.*

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_6

    >43 million

    estimated legal-age consumers of PMI’s smoke-free products.**

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_4

    110 markets

    where our smoke-free products are available, providing better alternatives for legal-age smokers.*

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_5

    >16 USD billion

    invested in smoke-free products since 2008.**


*As of Q3 2026. **As of December 31, 2025. Important note: This information should be read in conjunction with the Philip Morris International Inc. earnings release dated October 21, 2026, as well as the accompanying glossary of key terms, definitions, explanatory notes, select financial information and reconciliations of non-GAAP financial measures, both of which are available on our Investor Relations page. “PMI,” “we,” “our,” and “us” refers to the entire Philip Morris International family of companies.

 

Highlights of PMI’s Q3 2026 results

The Group Chief Financial Officer for Philip Morris International discusses the highlights of the Q3 2026 earnings report.

0:02:05

Massimo Andolina shares his highlights from our Q3 2026 Results

Massimo Andolina, Group Chief Financial Officer for Philip Morris International, speaks to camera:

We delivered an excellent third quarter. Our smoke-free business continued to perform strongly, demonstrating the power of our multicategory strategy.

IQOS remains the driving force.

We are excited by ZYN's initial momentum in the U.S. as we expand our portfolio, and VEEV delivered another outstanding quarter.

Alongside a standout performance from our combustible business, we achieved strong volume, net revenue, and profit growth, while generating robust cash flow.

This allows us to keep investing in smoke-free growth and focus on creating long-term value.

Financial disclaimer appears on screen. 

Music ends.

Explore our smoke-free progress

Learn about our ambition, approach and progress

Shaping the future

FDA issues modified risk tobacco product orders for Philip Morris International’s nicotine pouches

This decision makes our nicotine pouches the first to receive modified risk tobacco product orders, authorizing reduced-risk claims compared to cigarettes.

Read about the FDA authorization

Human cognition: The next frontier?

Explore PMI’s white paper on human cognition and its role in the age of AI, highlighting why human thinking remains essential.

Explore the Cognition Hub

Taskforce on Nature-related Financial Disclosures (TNFD) Report 2026

PMI’s first TNFD Report sets out how we identify, evaluate, and manage nature-related dependencies, impacts, risks, and opportunities.

Read our TNFD report

The people behind our progress

Explore the voices, conversations, and insights behind PMI’s smoke-free progress.

Leaders of Change

PMI’s thought leaders share their insights and expertise on the changing face of business and how companies must pivot today to deliver a better tomorrow.

Read more

Voices of change

Voices of Change shares practical insights from PMI people on new ways of working, mentoring, resilience and helping teams succeed.

Read more

Let’s talk

We answer some of the most-asked questions about our vision for a smoke-free future, our better alternatives to cigarettes, preventing youth from accessing nicotine products, sustainability, and more.

Read more

See the progress we are making across the world 

Explore the interactive story of PMI’s smoke-free journey

Progress in action

Discover stories and milestones shaping our smoke-free future

Progress in action
  • Celebrating 10 years of smoke-free progress

    Read more
  • FDA authorizes sale of IQOS in the US

    Read more
  • Our commitment to preventing underage use of our smoke-free products

    Read more